Merck Czech Republic's total assets reached CZK 774 mil at the end of 2017, up 6.64% compared to the previous year.
Current assets amounted to CZK 604 mil, or 78.1% of total assets while cash stood at CZK 25.1 mil at the end of 2017.
By contrast, total debt reached CZK 0 mil at the year-end, or 0% of total assets, while the firm's equity amounted to CZK 674 mil. As a result, net debt stood at CZK -25.1 mil at the end of 2017 and accounted for -3.73% of equity.
Net debt against equity is down 44.0 pp from five years ago (40.2%). The ratio against EBITDA decreased from 1.39x seen in 2012 to -0.345x.
The company’s cost of funding amounted to in 2017, down 27.1 pp compared to the average over the last 5 years.
You can see all the company’s data at Merck Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
